Category Archives: Genetics

Genetics causing arthritis possibly helped humans survive Ice – Kasmir Monitor

Editor in Chief : Zafar Meraj Email: zafarmeraj@gmail.com Editor & Publisher : Shamim Meraj Email: shamim.meraj@gmail.com Advertising & Circulation : Irfan Malik (+91-9419036322) Email: irfanmalikm@gmail.com Printed at : Abid Enterprises (Zainakote), Srinagar Published from : 1 Residency Road, Press Enclave, Srinagar - 190001 Editorial : Ph No: +91-2452217, 2452578 FAX: +91-194-2477676 Feedback & Suggestions : kashmirmonitor@gmail.com

View post:
Genetics causing arthritis possibly helped humans survive Ice - Kasmir Monitor

Interleukin Shutting Down Genetic Testing Program, Lays Off Staff – GenomeWeb

NEW YORK (GenomeWeb) Interleukin Genetics on Monday announced that it would suspend its genetic testing program for severe gum disease and elevated systemic inflammation over the next 60 days after it was unable to defer a debt payment.

The Waltham, Massachusetts-based firm said it would also lay off five employees, or 63 percent of its current workforce. The decisions come as the company pursues strategic alternatives, Interleukin CEO Mark Carbeau said in a statement.

Registering provides access to this and other free content.

Already have an account? .

Read more here:
Interleukin Shutting Down Genetic Testing Program, Lays Off Staff - GenomeWeb

Genetics of Harry Potter: What wizardry can tell us about our DNA – Genetic Literacy Project

[In the world of Harry Potter,] magic appears to follow some of the same rules as other traits that are inherited, but what could be the genetic factors that explain why someone is born a witch or a wizard or without any magical ability at all?

A roomful of people at Future Con got a crash course in wizarding DNA and the basic workings of genetics on June 17, at a talk hosted by Eric Spana, an assistant professor in the Department of Biology at Duke University, in North Carolina.

Eric Spana describes wizard DNA at the Future Con panel, Harry Potter and the Genetics of Wizarding. Credit: M. Weisberger/Live Science

Is the wizarding gene recessive? Hagrid, the half-giant-half-wizard groundskeeper at Hogwarts, proves that it isnt, according to Spana. Giants have no magical ability, and Hagrid was born to a giant mother and a wizard father. For him to be born a wizard with only one copy of the wizard gene in his DNA, magical ability would have to be a dominant trait, said Spana.

If the wizarding gene is working correctly, it makes a certain type of protein. The phenotypeis magical ability. But if theres amutation in that gene Spana suggested calling it the SQUIB mutation a different type of protein turns the magic gene off. If one parents DNA carries a copy of the SQUIB mutation, it can turn off the wizarding protein, which cancels a childs ability to do magic.

We do this in fruit flies all the time, Spana said, referring to manipulation of heritable traits in general.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:Genetics of Wizardry: Were Harry Potters Magical Powers Written in His DNA?

Here is the original post:
Genetics of Harry Potter: What wizardry can tell us about our DNA - Genetic Literacy Project

Genetics may lie at the heart of crop yield limitation – Phys.org – Phys.Org

July 5, 2017 Comparison of growth differences in wild-type (left) and growth-repressor mutant (right) Arabidopsis plants. Credit: Dr Nick Pullen

You might think that plants grow according to how much nutrition, water and sunlight they are exposed to, but new research by Dr Nick Pullen and a team from the John Innes Centre, UK shows that the plant's own genetics may be the real limiting factor.

"This could have potentially big implications for the agricultural industry," says Dr Pullen, "Our model plant is in the same family as cabbages, so it's easy to imagine creating giant cabbages or growing them to the desired market size faster than at present."

It was previously assumed that plant growth was generally resource-limited, meaning that plants would only grow as large and fast as they could photosynthesise. However, Dr Pullen and his team present evidence that plant growth is actually "sink-limited", meaning that genetic regulation and cell division rates have a much bigger role in controlling plant growth than previously thought: "We are proposing that plant growth is not physically limited by Net Primary Productivity (NPP) or the environment, but instead is limited genetically in response to these signals to ensure they do not become limiting."

By genetically altering the growth repressors in Arabidopsis, Dr Pullen and his team were able to create mutant strains. They identified the metabolic rates of the different plant strains by measuring rates of photosynthesis and respiration, as well as comparing the size and weight of the plants to monitor differences in physical growth.

Dr Pullen and the team also grew the mutant plant strains at different temperatures to see if this changed their results: "When grown at different temperatures we still find a difference in size of our plants between wildtype and the mutants. This suggests our results should be applicable in different climates."

The impact of these results is wide-reaching, and Dr Pullen suggests that it may even change how we think about global climate data: "Climate models need to incorporate genetic elements because at present most do not, and their predictions would be much improved with a better understanding of plant carbon demand."

Explore further: Revealed: New step in plant mastermind hormone's pathway

Plants are stationary. This means that the way they grow must be highly internally regulated to use the surrounding resources in the most-advantageous way possible.

Garden and potted plants with white spots on their leaves are so popular that they are specially selected for this feature. An international research team has now identified a new mutation in the plant Lotus japonicus which ...

Researchers have discovered a new gene that enables plants to regulate their growth in different temperatures.

Scientists have identified a new mutant plant that accumulates excessive amounts of starch, which could help to boost crop yields and increase the productivity of plants grown for biofuels.

New research from an Iowa State University scientist identifies a genetic mechanism that governs growth and drought tolerance in plants, a development that could lead to better performing traits in crops.

Because plants cannot relocate when resources become scarce, they need to efficiently regulate their growth by responding to environmental cues. Drought is the most important cause of reduced plant growth and crop yield, ...

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have undertaken the first ever comprehensive analysis of autophagy in a living animal during aging. "Autophagy," which means "self-eating" based on its ...

When exposed to potential predators as an embryo, the invasive American bullfrog becomes harder to kill when it becomes a tadpole, according to a new study by Oregon State University researchers.

Moving genes about could help cells to respond to change according to scientists at the Babraham Institute in Cambridge, UK and the Weizmann Institute, Israel. Changing the location of a gene within a cell alters its activity. ...

Even though malaria still kills one child every minute, the vast majority of those infected still survive, with roughly 200 million new infections every year. A new study has shown that the infectious agent responsible for ...

Muscles require energy to perform all of the movements that we do in a day, and now, for the first time, researchers at the Texas A&M College of Medicine have shown how muscles "request" more energy from fat storage tissues ...

Scientists at Johns Hopkins, Rutgers, the University of Trento in Italy, and Harvard Medical School report they have developed a new molecular technique called LASSO cloning, which can be used to isolate thousands of long ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Continued here:
Genetics may lie at the heart of crop yield limitation - Phys.org - Phys.Org

Konica Minolta, With Eye on Health Care, Nears Deal for U.S. … – New York Times

An announcement is expected on Thursday, and the companies hope to complete the transaction by the end of the year. Ambry Genetics declined to comment.

The Japanese government is helping to drive the diversification efforts. A state-backed investment fund, the Innovation Network Corporation of Japan, is teaming up with Konica Minolta in the Ambry acquisition. According to the people familiar with the deal, Konica Minolta would take a 60 percent share in Ambry, with the rest to be acquired by the fund.

Ambry, which is privately held, would retain its current leadership, these people said. The management team includes the company founder and chairman, Charles L. M. Dunlop, who has said his own experience with prostate cancer now in remission influenced his decision to make public anonymized information from Ambrys database.

Pooling data from many people is considered crucial to finding genetic elements that contribute to illnesses.

For Konica Minolta, the acquisition would confirm the acceleration of efforts to diversify beyond photocopiers and printers, areas where revenue and profit have been shrinking.

The Japanese company has identified health care, and cancer screening in particular, as a possible mainstay of business. It has been developing its own cancer-detecting technology using light-emitting nanoparticles to mark proteins that are drawn to cancer cells.

Other Japanese businesses have tried similar expansions. Fujifilm, for instance which, like Konica Minolta, built a name decades ago in photography has established a profitable health care and cosmetics division, helping it survive the end of the analog film era.

Other Japanese groups health care ventures have been less successful, however.

Follow Jonathan Soble on Twitter @jonathan_soble.

Chad Bray contributed reporting from London.

Read more:
Konica Minolta, With Eye on Health Care, Nears Deal for U.S. ... - New York Times

Genetics College of Agriculture and Life Sciences | School …

Welcometo the University of Wisconsin-Madison Laboratory of Genetics. The Laboratory of Genetics is comprised of two sister departments that function as one. The Department of Genetics in the College of Agricultural and Life Sciences was founded in 1910 and is the oldest genetics department in the country. The Department of Medical Genetics, which recently celebrated its fiftieth anniversary, is housed within the School of Medicine and Public Health. Our mission is to address fundamental problems in genetics as they relate to medicine, agriculture, and basic knowledge of biology.

The Laboratory of Genetics is also home to the Genetics Training Program, with over 80 faculty trainers from diverse departments on campus that together provide graduate students diverse opportunities in modern genetics research. Please visit our pages to find out more about us.

John Doebley Chair, Laboratory of Genetics

Go here to see the original:
Genetics College of Agriculture and Life Sciences | School ...

Genetics | CTCA

Cancer is triggered by mutations (changes) in the genes of a cell. These changes cause cells to reproduce in an unstructured, abnormal way. Most cancers occur by chance or sporadically. Gene changes may result from a random mistake when cells are dividing. Genes may also change in response to lifestyle habits and/or environment exposures or injuries.

A small portion of cancers have been identified as resulting from genetic changes that are inherited. Individuals with an inherited gene mutation tendency have an increased risk of developing cancer in their lifetime. However, not everyone who is born with a tendency for a gene mutation will develop cancer.

At Cancer Treatment Centers of America (CTCA) we offer genetic testing to help determine if your cancer was due to an inherited gene mutation and if you are at an increased risk of developing a second cancer.

Our Cancer Genetics Program consists of genetics education, counseling and testing services. You will learn about the role of genes and hereditary in the development of cancer and which of your family members may be affected. Before and after your test, you will meet with a genetic counselor to discuss your questions and concerns.

CTCA also offers genomic tumor assessment to help uncover genetic changes occurring within the tumor itself. Identifying these changes may help determine whats driving the growth of cancer. With this information, our physicians can better understand whats driving the growth of the cancer and find treatment options not previously considered.

The terms genetics and genomics may seem similar. Both refer to the genes in an individual. But genetics looks only at the traits you inherited from your parents, while genomics is focused exclusively on whats happening to the genes of an individual tumor.

Watch our video above to learn more about the difference.

See more here:
Genetics | CTCA

Hendrix Genetics Plans Hatchery-Egg Production Facility In Beresford, South Dakota – Area Development Online

News Items

According to state officials the company will directly distribute quality Hybrid commercial poults to growers. The investment plan includes new hatcheries, egg production facilities, a modern transportation fleet, and the hiring of skilled workforce needed to support these areas of operations.

This new hatchery allows us to continue to deliver on our core focus of providing top quality genetics that match the needs of the market and our customers. This is a critical component of our plan to modernize the commercial turkey distribution infrastructure in the USA, said Dave Libertini, Managing Director.

South Dakota is consistently recognized as a top state in the nation to do business. Hendrix Genetics made the right decision to expand to our state. Theyll find a skilled and productive workforce in the Beresford region. Were proud to call Hendrix Genetics South Dakotas newest corporate citizen, said Governor Dennis Daugaard.

The proposed turkey hatchery in Beresford will have capacity for 35 million hatching eggs. The new hatchery, plus the capacity within the aligned partners, offers the capability of hatching 60 million eggs for the commercial market, officials said. The facility will be outfitted with cutting-edge equipment, featuring Petersime incubators, to ensure the highest biosecurity and poult quality.

Adjacent to Interstate 29 between Sioux Falls and Sioux City, Beresford is well connected to the interstate system to transport day-old poults to the USA market, state officials said. In addition, access to a skilled workforce and the support of the local community were elements of the decision process for Hendrix Genetics.

We are so fortunate Hendrix Genetics picked Beresford for its new hatchery. I could not be more pleased and excited to have a company of this caliber joining our community. When you consider that we are getting a quality company, 50+ jobs, more people living in our town and more kids in our great school system, this really becomes a win-win for the city of Beresford, said Mayor Jim Fedderson, City of Beresford.

Read the rest here:
Hendrix Genetics Plans Hatchery-Egg Production Facility In Beresford, South Dakota - Area Development Online

Interleukin Genetics slashes workforce, explores options – BioPharma Dive

Dive Brief:

Interleukin Genetics attempted to restructure its debts back in April, entering into a rejiggered agreement with Horizon Technology Finance which deferred the principal amount owed to the lender on April 1, May 1 and June 1. The deferral could have continued each month through September, but the borrower had to lock down by June 15 a "clinical services agreement" that had the approval of Horizon Technology Finance.

That didn't happen, and now Interleukin Genetics is doing whatever it can to gain capital.

"While this decision was extremely difficult, it is important to preserve capital as we assess our options," Interleukin Genetics CEO Mark Carbeau said in a July 3 statement. The company did not immediately respond to BioPharma Dive request for comment.

Interleukin Genetics also said in the statement it had about $925,000 in cash on hand as of June 30. Due to the strategic evaluation, its second quarter financial filings with the Securities and Exchange Commission will be coming in late.

Horizon Technology Finance initially loaned $5 million to the borrower back in late 2014. The parties agreed that Interleukin Genetics would repay the loan over 45 months, with the first 15 months being only interest payments and the latter 30 being equal payments of the total principal plus interest. The revamped agreement from earlier this year offered Interleukin Genetics a few months of deferred payments in exchange for an estimated 5.5 million to 11 million shares of the company's common stock.

Even if the borrower had secured a clinical services partnership and been able to keep the payment deferrals going a few more months, it has had trouble generating revenue.

Interleukin Genetics garnered nearly $200,000 in total revenue during the first quarter, down from almost $961,000 during the same period in 2016, which the company attributed to a decline in contracted research projects. A $2.3 million loss from operational costs led the company to have a net loss of $2.5 million for the first three months of 2017.

Moving forward, the company expects its main assets will be its Clinical Laboratory Improvement Amendments-certified testing and the intellectual property for its diagnostic programs, including Ilustra and the Inherent Health brand. It also expects the current restructuring efforts will cost $245,000.

See original here:
Interleukin Genetics slashes workforce, explores options - BioPharma Dive